Skip to main content
All lobbying filings

AMERICAN CLINICAL LABORATORY ASSN

Lobbying for AMERICAN CLINICAL LABORATORY ASSN

 Filing 2nd Quarter - Report
2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate · $890,000.00 expenses · posted Jul 17, 2026

Official filing document

 Bills named in this filing 9
  • HR 5269
    RESULTS Act
  • S 2761
    RESULTS Act
  • HR 3514
    Improving Seniors’ Timely Access to Care Act of 2025
  • S 1816
    Improving Seniors’ Timely Access to Care Act of 2025
  • HR 9396
    Prior Authorization Accountability Act
  • HR 5582
    Patients Deserve Price Tags Act
  • S 2355
    Patients Deserve Price Tags Act
  • HR 9393
    Lower Costs, More Transparency Act of 2026
  • HR 7961
    H–1Bs for Physicians and the Healthcare Workforce Act
 Lobbying activity 4
Medical/Disease Research/Clinical Labs

Issues related to reimbursement and coverage for clinical laboratory services, including the Medicare clinical laboratory fee schedule; implementation of the Protecting Access to Medicare Act (P.L. 113-93) and the Consolidated Appropriations Act, 2026 (P.L. 119-75); RESULTS Act (H.R. 5269/S. 2761); diagnostic regulatory reform; artificial intelligence in laboratory services; laboratory coding, pricing, coverage, and payment.

Medicare/Medicaid

Issues related to reimbursement and coverage for clinical laboratory services, including the Medicare clinical laboratory fee schedule; implementation of the Protecting Access to Medicare Act (P.L. 113-93) and Consolidated Appropriations Act, 2026 (P.L. 119-75); RESULTS Act (H.R. 5269/S. 2761); laboratory coding, pricing, coverage, and payment; Improving Seniors' Timely Access to Care Act (H.R. 3514/S. 1816); Prior Authorization Accountability Act (H.R. 9396); program integrity initiatives.

Health Issues

Issues related to reimbursement and coverage for clinical laboratory services, including the Medicare clinical laboratory fee schedule; implementation of the Protecting Access to Medicare Act (P.L. 113-93) and the Consolidated Appropriations Act, 2026 (P.L. 119-75); RESULTS Act (H.R. 5269/S. 2761); diagnostic regulatory reform; Patients Deserve Price Tags Act (H.R. 5582/S. 2355); Lower Costs, More Transparency Act (H.R. 9393).

Immigration

H-1Bs for Physicians and Healthcare Workforce Act (H.R. 7961).

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem